s6y
Company name or ticker
Search
Opus Genetics, Inc.
4
Foundation Fighting Blindness Retinal Degeneration Fund: Statement of changes in beneficial ownership of securities
Filed
Friday, October 2, 2026
Period
Sep 30, 2026
Accession number
0002042266-26-000002
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header